3420 Central Expressway
Santa Clara, CA 95051
www.affymetrix.com
Public
NASDAQ:AFFX
 Synopsis: Business Condition
Year Founded 1991
Employment 900
Sector Technology
Industry Scientific & Technical Instruments
Affymetrix Inc
     Last modified on: 8/28/2013

Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The company offers integrated GeneChip microarray platform that includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. Its products are used in various applications, including genotyping and gene expression. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers; government research laboratories; private foundation laboratories; and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, India, the Middle East, and the Asia Pacific regions, including the People’s Republic of China. It has collaboration partnerships with Beckman Coulter, Inc.; CapitalBio Corporation; Life Technologies, Inc.; Genisphere LLC; and Qiagen GmbH. The company has operations in the United States, Europe, and Japan. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.